Compression Stockings After DVT
Routine use of graduated compression stockings is not recommended for preventing post-thrombotic syndrome (PTS) after DVT, based on the most recent high-quality evidence showing no benefit when compared to placebo stockings. 1
Current Guideline Recommendations
The American Society of Hematology (2020) provides a conditional recommendation against routine use of compression stockings for patients with DVT, regardless of whether they have increased risk for PTS or not. 1 This represents a significant shift from earlier practice, driven primarily by the large, double-blinded SOX trial which contradicted earlier open-label studies. 1
Key Evidence Behind This Recommendation
No reduction in PTS incidence: When analyzing only low-risk-of-bias trials (primarily the SOX trial with 806 patients), compression stockings showed no benefit (RR 1.01,95% CI 0.76-1.33) compared to placebo stockings. 1
Earlier positive trials likely biased: The landmark studies by Brandjes et al (1997) and Prandoni et al (2004) showed dramatic 50% reductions in PTS rates with 30-40 mm Hg knee-high stockings. 2, 3 However, these were open-label designs comparing stockings versus no stockings, which likely introduced reporting and observer bias. 2
No mortality or PE benefit: Compression stockings have negligible effect on mortality (RR 0.99) and no significant reduction in pulmonary embolism risk (RR 0.72,95% CI 0.31-1.70). 1
When Stockings May Still Be Considered
Despite the recommendation against routine use, compression stockings may help reduce acute edema and pain associated with DVT in selected symptomatic patients. 1 This is a symptomatic indication rather than PTS prevention.
If Stockings Are Used for Symptom Relief
Pressure class: 30-40 mm Hg at the ankle is the most studied compression level. 2, 1
Length: Below-knee (knee-high) stockings are sufficient, as hemodynamic studies show no significant difference between below-knee and above-knee stockings in improving venous parameters. 4 Patient preference should guide length selection, as compliance is critical. 4
No distinction by DVT location: The evidence does not support different compression strategies for proximal versus distal DVT. 2, 1
Important Clinical Caveats
Adverse events are minimal: Serious adverse events are rare, with minor issues like rash or itching occurring in <2% of patients. 2
Compliance challenges: Even in clinical trials, only 56% of patients reported frequent use at 2 years, despite initial compliance of 93%. 2
Cost and burden: Some patients experience discomfort, skin breakdown, or find the cost prohibitive, which should factor into shared decision-making. 1
Practical Algorithm
Do not routinely prescribe compression stockings for PTS prevention after DVT diagnosis. 1
Consider for symptom management only if patient has significant leg edema or pain causing functional impairment. 1
If prescribed for symptoms: Use 30-40 mm Hg knee-high stockings, assess patient preference for length, and monitor for skin complications. 2, 1, 4
Focus anticoagulation optimization instead: Ensure therapeutic INR levels (if using warfarin) in the first few months, as this is a Class I recommendation for PTS prevention. 2